The Myositis Association (TMA) is proud to announce the inaugural Marianne Moyer Myositis Leader Award to be presented at the 2024 Heroes in the Fight Awards Celebration on September 7…
Continue Reading
CAR T-cell therapy: A viable option for myositis treatment?
Chimeric antigen receptor T-cell (CAR T-cell) therapy is a process developed to treat certain forms of cancers, especially blood cancers like leukemia and lymphoma. Recently, however, researchers have started exploring…
Continue Reading
Last call for comments for DM PFDD
TMA was honored to partner with Myositis Support and Understanding (MSU) to host the Externally Led Patient Focused Drug Development (PFDD) meeting for adult dermatomyositis (DM) on June 7. View…
Continue Reading
TMA’s top 10 travel tips
TMA’s top 10 travel tips help you achieve those bucket-list wishes, including making the most of our International Annual Patient Conference.
Continue Reading
Dermatomyositis: A many-headed monster
The first-ever Externally Led Patient Focused Drug Development (EL-PFDD) meeting on June 7 offered a critical way for patients and their family members to highlight what life with DM is like.
Continue Reading